Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy

OBJECTIVES: Paclitaxel (PTX) is frequently used in the clinical treatment of solid tumors. But the PTX-resistance is a great obstacle in cancer treatment. Exploration of the mechanisms of drug resistance suggests that tumor suppressor genes (TSGs) play a key role in the response of chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jia-Hui, Hu, Shi-Lian, Shen, Guo-Dong, Shen, Gan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761208/
https://www.ncbi.nlm.nih.gov/pubmed/26900348
http://dx.doi.org/10.1186/s12935-016-0290-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761208/
https://www.ncbi.nlm.nih.gov/pubmed/26900348
http://dx.doi.org/10.1186/s12935-016-0290-9

Ejemplares similares